Collagen Vascular Diseases and Enhanced Radiotherapy-induced Normal Tissue Effects - a Case Report and a Review of Published Studies

Clinical Oncology

Volumn 23, Issue 2, 2011, Pages 73-78

  Lee, C E ^a   Prabhu, V ^b   Slevin, N J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

Acute; Collagen; Disease; Late; Radiotherapy; Toxicity

Indexed keywords

METHOTREXATE; MORPHINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CELL DIFFERENTIATION; COLLAGEN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EDEMA; ENDOSCOPY; EPIGLOTTIS; HUMAN; HUMAN TISSUE; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NOSE FEEDING; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SKIN EXFOLIATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

CARCINOMA; COLLAGEN DISEASES; COMBINED MODALITY THERAPY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RADIATION INJURIES; RADIOTHERAPY; VASCULAR DISEASES;

EID: 79251638772     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.08.030     Document Type: Article

References (49)

1. Su R., Tang Y.M. Handbook of dermatology and dermatology venerology 2003, Government and Nonprofits, Social Hygiene Handbook. 2nd ed.
2. Abu-Shakra M., Lee P. Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy. J Rheumatol 1993, 20:1601-1603.
3. Lee P., Alderdice C., Wilkinson S., et al. Malignancy in progressive systemic sclerosis: association with breast cancer. J Rheumatol 1983, 10:665-666.
4. Roumm A.D., Medsger T.A. Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum 1985, 23:227-229.
5. Sultan S.M., Ioannou Y., Isenberg D.A. Is there an association of malignancy with systemic lupus erythematosus? an analysis of 276 patients under long term review. Rheumatology (Oxford) 2000, 39:1147-1152.
6. Brush J., Scott L., Lipnick B.S., et al. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol (US) 2007, 17(2):121-130.
7. Hareyama M., Nagakura H., Tamakawa M., et al. Retropharyngeal abscess after radiation therapy and cis-platinum, 5-fluorouracil treatment for nasopharyngeal carcinoma with collagen disease: report of two patients and a review of the literature. Jpn J Clin Oncol 1996, 26:189-193.
8. Gupta N.K., Swindell R. Concomitant methotrexate and radiotherapy in advanced head and neck cancer: 15 year follow up of a randomized clinical trial. Clin Oncol 2001, 13(5):339-344.
9. Chon B.H., Loeffler J.S. The effect of non malignant systemic disease on tolerance to radiation therapy. Oncologist 2002, 7:136-143.
10. Morris M.M., Powell S.N. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997, 15:2728-2735.
11. Varga J., Haustein U.F., Creech R.H., et al. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 1991, 265:3292-3295.
12. Trattner A., Figer A., David M., et al. Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 1991, 68:2131-2133.
13. McCormick B. Selection criteria for breast conservation: the impact of young and old age and collagen vascular disease. Cancer 1994, 74:430-435.
14. Robertson J.M., Clarke D.H., Pevzner M.M., et al. Breast conservation therapy severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 1991, 68:502-508.
15. Ross J.G., Hussey D.H., Mayr N.A., et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 1993, 71:3744-3752.
16. Fleck R., McNeese M.D., Ellerbroek N.A., et al. Consequences of breast irradiation in patients with pre existing collagen vascular diseases. Int J Radiat Oncol Biol Phys 1989, 17:829-833.
17. Teo P., Tai T.H., Choy D. Nasopharyngeal carcinoma with dermatomyositis. Int J Radiat Oncol Biol Phys 1989, 16:471-474.
18. Delanian S., Maulard-Durdux C., Lefaix J.L., et al. Major interactions between radiation therapy and systemic sclerosis: is there an optional treatment?. Eur J Cancer 1996, 32A:738-739.
19. Rakfal S.M., Deutsch M. Radiotherapy for malignancies associated with lupus; case reports of acute and late reactions. Am J Clin Oncol 1998, 21:54-57.
20. Olivotto I.A., Fairey J.H., Gillies J.H., et al. Fatal outcome of pelvic radiotherapy for carcinoma of the cervix in a patient with systemic lupus erythematosis. Clin Radiol 1989, 40:83-84.
21. Rathmell A.J., Taylor R.E. Enhanced normal tissue response to radiation in a patient with discoid lupus erythematosus. Clin Oncol 1992, 4:331-332.
22. Ransom D.T., Cameron F.G. Scleroderma - a possible contra indication to lumpectomy and radiotherapy in breast carcinoma. Australas Radiol 1987, 31:317-318.
23. Chen A.M., Obedian E., Haffty B.G. Breast conserving therapy in the setting of collagen vascular disease. Cancer J 2001, 7:480-491.
24. Khoo V.S., Saunders M.P., Gowda R., et al. Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression. Clin Oncol 2004, 16(1):1-5.
25. Cooper S.G., Denham J.W. Progressive systemic sclerosis and radiotherapy. Br J Radiol 1990, 63:804-805.
26. De Naeyer B., De Meerleer G., Braems S., Vakaet L., Huys J. Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 1999, 44(5):975-980.
27. Holscher T., Bentzen S.M., Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. Radiother Oncol (Ireland) 2006, 78(2):123-130.
28. Lin A., Abu-Lsa E., Griffith Kent A., et al. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer 2008, 113(3):648-653.
29. Phan C., Mindrum M., Silverman C., et al. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 2003, 9:461-466.
30. Gold D.G., Miller R.C., Patersen I.A., et al. Radiotherapy for malignancy in patients with scleroderma: the Mayo Clinic experience. Radiother Oncol 2008, 87(1):127-131.
31. Pinn M.E., Gold D.G., Petersen I.A., et al. Radiotherapy and systemic lupus erythematosus: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2007, 69(3):S544-545.
32. Mayr N.A., Riggs C.E., Saag K.G., et al. Mixed connective tissue disease and radiation toxicity. A case report. Cancer 1997, 79(3):612-618.
33. Bliss P., Parsons C.A., Blake P.R. Incidence and possible aetiological factors in the development of pelvic insufficiency fractures following radical radiotherapy. Br J Radiol 1996, 69:548-554.
34. Gold D.G., Miller R.C., Pinn M.E., et al. Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity. Radiother Oncol 2008, 87:127-131.
35. Krieg A.M. CpG DNA: a pathogenic factor in systemic lupus erythematosus?. J Clin Immunol 1995, 15:284-292.
36. Isselbacher K., Braunwald E. Harrisons principles of internal medicine 1994, The McGraw Hill Companies, Maidenhead, Berkshire: New York; pp. 1922-1974.
37. Rose L.M., Latchman D.S., Isenberg D.A. Bcl-2 and Fas, molecules which influence apoptosis: a possible role in systemic lupus erythematosus?. Autoimmunity 1994, 17:271-278.
38. Chanbazian C.M. Radiation oncology 1989, St Louis, The CV Mosby Company. 6th ed.
39. Matthews R.H. Collagen vascular disease and irradiation. Int J Radiat Oncol Biol Phys 1989, 17:1123-1124.
40. Hareyama M., Nagakura H., Tamakawa M., et al. Severe reaction after chemoradiotherapy of nasopharyngeal carcinoma with collagen disease. Int J Radiat Oncol Biol Phys 1995, 33:971.
41. Hall E.J. Radiobiology for the radiologist 1994, Lippincott, Philadelphia, PA, pp. 211-229. 4th ed.
42. Martin M., Remy J., Daburon F. In vitro growth potential of fibroblasts isolated from pigs with radiation-induced fibrosis. Int J Radiat Biol 1986, 49:821-828.
43. Canney P.A., Dean S. Transforming growth factor beta: a promoter of late connective tissue injury following radiotherapy. Br J Radiol 1990, 63:620-623.
44. Kumar S., Kolozsvary A., Kohl R., et al. Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis. Radiat Oncol 2008, 3:40.
45. Evans E.S., Hahn C.A., Kocak Z., et al. The role of functional imaging in the diagnosis and management of late normal tissue injury. Semin Radiat Oncol (US) 2007, 17(2):72-80.
46. Kahalek B.M., LeRoy C.E. Treatment and clinical manifestations as related to pathogenesis. Prog Clin Rheumatol 1984, 1:71-110.
47. Spronk P.E., Limburg P.C., Kallenberg C.G. Serological markers of disease activity in systemic lupus erythematosus. Lupus 1995, 4:86-94.
48. Budach W., Hartford A., Gioioso D., et al. Tumours arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Res 1992, 52:6292-6296.
49. Gery B., Little J. Modulation of human tumour cell proliferation and radiosensitivity after contact with fibroblast supernatant. Bull Cancer (Radiother) 1993, 80:455.